Previous 10 | Next 10 |
2023-04-18 06:40:45 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Many investors look for growth opportunities wherever they can find them. If that describes you, then there are some high-growth biotech stocks that could present an opportunity. ...
Precigen Presents Preclinical Data for the Next Generation Mesothelin UltraCAR-T® with Intrinsic PD-1 Blockade at the AACR Annual Meeting 2023 PR Newswire – First preclinical data presented for the next generation of the UltraCAR-T platform utilizing a mesothelin (...
2023-04-03 16:48:12 ET Precigen ( NASDAQ: PGEN ) amended its exclusive license agreement with Alaunos Therapeutics to use UltraCAR-T platform for development and commercialization of two CAR-T targets, CD19 and B-cell maturation antigen, in order to bolster portfolio and...
Precigen Regains Exclusive Rights to Proven CAR-T Targets, CD19 and BCMA, to Enable Unencumbered Development and Commercialization of UltraCAR-T® PR Newswire – Precigen amends exclusive license agreement with Alaunos to bolster portfolio and broaden strategic o...
2023-03-29 12:30:01 ET Precigen ( NASDAQ: PGEN ) stock rose ~12% on Wednesday after the company said that the first patient was dosed in a phase 1/1b trial of PRGN-3007 to treat advanced ROR1-positive (ROR1 + ) blood and solid tumors. The target population for...
Precigen Announces Further Advancement of UltraCAR-T® Platform with First Patient Dosed in Phase 1/1b Dose Escalation/Dose Expansion Study of PRGN-3007 in Advanced ROR1+ Hematological and Solid Tumors PR Newswire – Milestone represents the first patient dosed with ...
Precigen to Participate in a Virtual Fireside Chat at Cantor's "The Future of Oncology" Virtual Symposium PR Newswire GERMANTOWN, Md. , March 28, 2023 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development o...
2023-03-13 06:34:29 ET Precigen ( NASDAQ: PGEN ) disclosed in a SEC filing on Monday that it has "minimal exposure" to Silicon Valley Bank (SVB), which failed Friday and was closed down by California . Despite the bank's closure, the biotechnology company reaffirmed it...
2023-03-07 12:39:41 ET Gainers: ThredUp ( TDUP ) +73% . WW International ( WW ) +49% . Unicycive ( UNCY ) +39% . Protagonist Therapeutics ( PTGX ) +32% . Bionomics ( BNOX ) +28% . Novo Integrated Sciences ( NVOS ) +25% ...
2023-03-07 11:35:38 ET Jerome Powell takes center stage today and tomorrow with his semiannual testimony. While it has brought plenty of volatility to the stock market, some asset classes are generally experiencing a bit more as a result. I’m talking about penny stocks and there ...
News, Short Squeeze, Breakout and More Instantly...
2024-06-03 14:30:04 ET Stifel Nicolaus analyst issues MARKET OUTPERFORM recommendation for PGEN on June 3, 2024 01:00PM ET. The previous analyst recommendation was Market Outperform. PGEN was trading at $1.53 at issue of the analyst recommendation. The overall analyst co...
2024-06-03 14:30:03 ET JMP Securities analyst issues UNDERPERFORM recommendation for PGEN on June 3, 2024 01:00PM ET. The previous analyst recommendation was Underperform. PGEN was trading at $1.53 at issue of the analyst recommendation. The overall analyst consensus : B...
Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete Response PR Newswire – Phase 1/2 pivotal study met the primary safety and efficacy endpoints ...